AAO-HNS/F 2022 Virtual Leadership Forum & BOG Spring Meeting Agenda

2022 Leadership Forum Logo


9:00 AM

Welcome and Opening Remarks
Troy D. Woodard, MD, Chair, AAO-HNS/F Board of Governors

9:05 – 10:45 AM

Practice Management Program

  • OTC Audiology: How to Prepare your Practice
    Brian Woodhead, MGA, Johns Hopkins University
    Yuri Agrawal, MD, Johns Hopkins University
    Colleen E. Ryan, MS, Johns Hopkins University
    Morag Muirhead, Johns Hopkins Medicine
  • Best Practices in Utilizing APPs in Your Practice
    Craig Kilgore, CEO, Charleston Ear, Nose & Throat
    Dianne Williams, ENT Associates of Alabama
  • Private Equity: What You Need to Know
    Todd Blum, PhD, CEO, ENT & Allergy Associates of Florida

10:50 – 11:20 AM

Coding, Billing, and Reimbursement Update
Peter Manes, MD, Yale School of Medicine

11:25 AM – 12:00 PM

Legislative Update
Greg Murphy, MD (03-NC) U.S. House of Representatives

12:00 – 12:45 PM


12:45 – 1:30 PM

Raise Your Voice: Paving the Path for an Equitable Future
Kate Stewart, ENT, Stryker

1:35 – 2:20 PM

Healthcare at the Grass Roots Level
Joan Coker, MD, ENT & Allergy of Delaware

2:25 – 2:55 PM

AAO-HNS President-Elect Candidate Forum

3:00 – 3:40 PM

A Review of National Ambulatory Surgical Center Trends
William Prentice, Ambulatory Surgical Centers Association

3:45 – 4:30 PM

State Society Panel
Paul Shea, MD, Shea Ear Clinic
David Cognetti, MD, Thomas Jefferson University Hospital
David Boisoneau, MD, ENT Associates of SECT
Steven Kmucha, MD, JD, San Francisco-Peninsula Ear, Nose and Throat Associates

4:30 PM

Closing Remarks
Troy D. Woodard, MD, Chair, AAO-HNS/F Board of Governors

Presenter Disclosure of Relevant Financial Relationships

The AAO-HNSF is committed to creating high-quality education that is independent of industry influence. All persons who have been in control of this educational content for this accredited CE activity has been asked to disclose all financial relationships with any ineligible companies they have had over the past 24 months.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum threshold; all financial relationships, regardless of amount, with ineligible companies.

The ACCME also requires that AAO-HNSF manage any reported conflict and eliminate the potential for bias during the educational activity. All of the relevant financial relationships listed for these individuals have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

In addition, presenters will disclose their intent to discuss drugs or devices or the uses of drugs or devices that have not been approved by the Food and Drug Administration (FDA).

Planning Committee

Troy D. Woodard, MD
No relationships to disclose.


Tirza Lofgreen, CHCP
No relationships to disclose.

Elise Swinehart
No relationships to disclose.


Yuri Agrawal, MD
No relationships to disclose.

Gene G. Brown, III, MD
No relationships to disclose.

Todd Blum, PhD, MHA, MBA
No relationships to disclose.

David S. Boisoneau, MD
No relationships to disclose.

David Cognetti, MD
Consulting fee: Cortexyme;
Financial relationship: Intuitive



Joan Coker, MD
No relationships to disclose.

Andrew M Coughlin, MD
No relationships to disclose.

Craig Kilgore
No relationships to disclose.

Steven Kmucha, MD, JD
No relationships to disclose.

William Prentice
No relationships to disclose.

R. Peter Manes, MD
No relationships to disclose.

Lance A. Manning, MD
No relationships to disclose.

Morag Muirhead, MD
No relationships to disclose.

Eileen M. Raynor, MD
Stock options, Doximity



Karen A. Rizzo, MD
No relationships to disclose.

Colleen E. Ryan, MS
No relationships to disclose.

Paul Shea, MD
No relationships to disclose.

Kate Stewart
No relationships to disclose.

Yolanda L. Troublefield, MD, JD
No relationships to disclose.

Dianne Williams
No relationships to disclose.

Brian Woodhead, MGA
No relationships to disclose.

Clinical Medicine Recommendations/Scientific Research Reporting

The AAO-HNS informs all presenters and expects that:

  • All recommendations involving clinical medicine in a professional education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for the indications and contradictions in the care of patients; and
  • All scientific research referred to, reported, or used in professional education in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Free Exchange of Medical Education Statement

AAO-HNSF is committed to the free exchange of medical education. Inclusion of any presentation or exhibit in this activity, including presentations or exhibits on drugs or medical devices, or the uses of drugs or medical devices that have not been approved by the FDA, does not imply an endorsement by the AAO-HNSF of the uses, products, or techniques presented.

The information contained in this activity represents the views of those who created it and does not necessarily represent the official view or recommendations of AAO-HNSF.

AAO-HNS COVID-19 InformationLearn More